Toggle Health Problems and D

Study found little proof that preemies need more vitamin D – Sept 2013

Nutrition Support of Neonatal Patients at Risk for Metabolic Bone Disease

A.S.P.E.N. Clinical Guidelines

Deepika Nehra, MD1
Sarah J. Carlson, MD1
Erica M. Fallon, MD1
Brian Kalish, BS1
Alexis K. Potemkin, RN, BSN1
Kathleen M. Gura, PharmD, BCNSP2
Edwin Simpser, MD3
Charlene Compher, PhD, RD, CNSC, LDN, FADA4
Mark Puder, MD, PhD1
the American Society for Parenteral and Enteral Nutrition
1Department of Surgery and The Vascular Biology Program, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts
2Department of Pharmacy, Children’s Hospital Boston, Boston, Massachusetts
3St Mary’s Hospital for Children, Bayside, New York
4University of Pennsylvania School of Nursing, Philadelphia, Pennsylvania
Charlene Compher, PhD, RD, CNSC, LDN, FADA, University of Pennsylvania School of Nursing, Claire M. Fagin Hall, 418 Curie Blvd, Philadelphia, PA 19104-4217, USA. Email: compherc at nursing.upenn.edu.

Background: Premature infants are at increased risk for metabolic bone disease, with resulting delayed bone growth, osteopenia, and rickets. Method: A systematic review of the best available evidence to answer a series of questions regarding neonatal patients at risk of metabolic bone disease receiving parenteral or enteral nutrition was undertaken and evaluated using concepts adopted from the Grading of Recommendations, Assessment, Development and Evaluation working group. A consensus process was used to develop the clinical guideline recommendations prior to external and internal review and approval by the American Society for Parenteral and Enteral Nutrition Board of Directors. Questions:

  • (1) What maternal risk factors predispose the neonate to metabolic bone disease?
  • (2) What is the optimal type of feeding to promote neonatal bone health?
  • (3) When and how should vitamin D supplements be administered?
  • (4) Does parenteral nutrition (PN) predispose a neonate to metabolic bone disease, and if so, are there PN formulation recommendations to minimize this risk?

PDF is attached at the bottom of this page

See also VitaminDWiki

Attached files

ID Name Comment Uploaded Size Downloads
3004 JPEN J Parenter Enteral Nutr-2013-Nehra-570-98.pdf admin 15 Sep, 2013 803.82 Kb 854